Treatment of disseminated non-seminomatous testicular cancer: the European experience. - Wikidata - wikimedia - TriplyDB

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

http://www.wikidata.org/entity/Q33788904

about

Therapy of testicular cancer: a surgeon's view.Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

P2860

Q36066166-A36BF620-A71B-4B4B-9F08-08FBD4C7EE6D Q43910348-568FDFC6-03D2-4E6C-AA31-1E3A62F5787D

P2860

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

http://www.wikidata.org/entity/Q33788904

description

1999 nî lūn-bûn

@nan

1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@ast

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@en

type

label

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@ast

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@en

prefLabel

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@ast

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@en

P1433

Q33788904-05E77758-7F4C-4EB2-85B5-054C24D57B4B

P1476

Q33788904-54754B9E-ED8C-4666-AB8B-7F947DE7E3D5

P2093

Q33788904-669EAF1A-160C-4A39-8046-B7F3B4908E06

P2860

Q33788904-02DF5ECC-7DFE-42B9-9209-8084216E0011

Q33788904-10738A39-3B6E-4B4E-8A19-119E3FEFFAF7

Q33788904-2C3A27B3-4C8F-4E07-B2E5-5495F2E9F133

Q33788904-3EF5027C-91EC-4D30-81D0-2A9E7391B3F0

Q33788904-5616A703-56D7-4125-9D97-B39FD7C926D9

Q33788904-6EA1A7A8-449A-4E10-A48E-245C3ADDD2B4

Q33788904-805CCFE5-C332-49BC-A8D0-A59AFC73B502

Q33788904-BAE88737-31A6-41C1-B477-13DF488462AD

Q33788904-CDBF476C-AC53-4555-959C-2ABEC2BD6814

Q33788904-D7DB5439-1A47-4750-BA5A-D0481EF34EC8

P304

Q33788904-876385DD-4BF4-4596-AD2A-9F8DB410AE70

P31

Q33788904-15313A28-AA82-47D9-B99E-42333335D76D

P356

Q33788904-1C2975F4-02D5-4736-8386-7435F6DC56F9

P433

Q33788904-FC98BAF3-F277-4A4C-B0F3-DB4ACD689F27

P478

Q33788904-843BAA6A-63AE-45B6-BFE4-7E0C749CD9F9

P577

Q33788904-3727F8AC-FF46-45D1-8794-3EF1BEF12CEE

P698

Q33788904-710CFAD7-561D-48A9-B29A-E5FB854484C4

P356

(SICI)1098-2388(199912)17:4%3C250::AID-SSU5%3E3.0.CO;2-M

P1433

Journal of Surgical Oncology

P1476

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

@en

P2093

de Wit R

http://www.w3.org/2001/XMLSchema#string

P2860

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.

Treatment of testicular cancer: a new and improved model.

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.

Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

P304

250-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/(SICI)1098-2388(199912)17:4<250::AID-SSU5>3.0.CO;2-M

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10588853

http://www.w3.org/2001/XMLSchema#string